A Novel Metabolite of Antituberculosis Therapy Demonstrates Host Activation of Isoniazid and Formation of the Isoniazid-NAD + Adduct
- 1 January 2012
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (1), 28-35
- https://doi.org/10.1128/aac.05486-11
Abstract
One of the most effective and widely used antituberculosis (anti-TB) drugs is isoniazid (INH), a prodrug activated via oxidation that forms an adduct with NAD + to inhibit NADH-dependent targets of Mycobacterium tuberculosis , such as enoyl-acyl carrier protein reductase (InhA). The metabolic by-products and potentially toxic intermediates resulting from INH therapy have been identified through a large body of work. However, an INH-NAD adduct or structures related to this adduct have not been identified in specimens from human TB patients or animal models of TB. Analyses by mass spectrometry of urine collected from TB patients in a study conducted by the NIAID-funded Tuberculosis Research Unit identified 4-isonicotinoylnicotinamide (C 12 H 9 N 3 O 2 ) as a novel metabolite of INH therapy. This compound was formed by M. tuberculosis strains in a KatG-dependent manner but could also be produced by mice treated with INH independent of an M. tuberculosis infection. Thus, the 4-isonicotinoylnicotinamide observed in human urine samples is likely derived from the degradation of oxidized INH-NAD adducts and provides direct evidence of host INH activation.Keywords
This publication has 39 references indexed in Scilit:
- Development of isoniazid–NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agentsEuropean Journal of Medicinal Chemistry, 2010
- Mycobacterium tuberculosis Dihydrofolate Reductase Is Not a Target Relevant to the Antitubercular Activity of IsoniazidAntimicrobial Agents and Chemotherapy, 2010
- Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme PeroxidasesPublished by Elsevier BV ,2010
- Microbial NAD Metabolism: Lessons from Comparative GenomicsMicrobiology and Molecular Biology Reviews, 2009
- NAD+ metabolism in health and diseaseTrends in Biochemical Sciences, 2007
- Mn(III) Pyrophosphate as an Efficient Tool for Studying the Mode of Action of Isoniazid on the InhA Protein of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2002
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- Isoniazid-induced pellagra.BMJ, 1981
- ISONIAZID-INDUCED PELLAGRA DESPITE VITAMIN-B6 SUPPLEMENTATIONThe Lancet, 1979
- Pharmacokinetics of isoniazid metabolism in manJournal of Pharmacokinetics and Biopharmaceutics, 1976